1. 6296-53-3
2. N-(1,3-dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide
3. 3-acetylaminophthalic Anhydride
4. 1,3-dioxo-2-isoindolineaceticacid
5. N-(1,3-dioxo-2-benzofuran-4-yl)acetamide
6. Acetamide, N-(1,3-dihydro-1,3-dioxo-4-isobenzofuranyl)-
7. Mfcd00453138
8. N-(1,3-dihydro-1,3-dioxoisobenzofuran-4-yl)acetamide
9. N-(1,3-dioxo-4-isobenzofuranyl)acetamide
10. 4-acetamido-1,3-isobenzofurandione
11. Nsc16261
12. Acetamide,n-(1,3-dihydro-1,3-dioxo-4-isobenzofuranyl)
13. N-(1,3-dioxo-1,3-dihydro-2-benzofuran-4-yl)acetamide
14. 3-acetamidopthalic Anhydride
15. Schembl303302
16. 3-acetamido-phthalic Anhydride
17. 3-acetylaminophthalsaureanhydrid
18. N-(1,3-dioxo-1,3-dihydro-isobenzofuran-4-yl)acetamide
19. Amy4064
20. Dtxsid00978816
21. Bcp09393
22. Cs-m2812
23. Nsc17048
24. Nsc-16261
25. Nsc-17048
26. Zinc97957375
27. Akos002687661
28. Ds-7780
29. Ac-30405
30. Sy046903
31. Db-024694
32. Ft-0767491
33. A854757
34. N-(1,3-dihydro-1,3-dioxo-4-isobenzofuranyl)acetamide
35. N-(1,3-dioxo-1,3-dihydroisobenzo[b]furan-4-yl)acetamide
36. N-(1,3-dioxo-1,3-dihydro-2-benzofuran-4-yl)ethanimidic Acid
37. Not Available;n-(1,3-dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide
Molecular Weight | 205.17 g/mol |
---|---|
Molecular Formula | C10H7NO4 |
XLogP3 | 1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 1 |
Exact Mass | 205.03750770 g/mol |
Monoisotopic Mass | 205.03750770 g/mol |
Topological Polar Surface Area | 72.5 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 325 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs) and ...
3-ACETAMIDO PHTHALIC ANHYDRIDE
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Founded with a mission to transform strategic capital into specialty chemicals, Ami Group focuses on Agrochemicals, Cosmetics, and Polymers. Ami Organics Ltd. is committed to meeting yo...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Aventus Labs is a forward-thinking pharmaceutical company committed to developing and delivering high-quality, effective healthcare solutions. With a focus on rigorous research and adhe...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Glenfin Chemicals, a trusted provider of high-quality chemical solutions tailored to meet the diverse needs of industries worldwide. Based in the heart of innovation and excellence, we...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : TEXLAB INDUSTRIES was established in 1971, manufacturing & trading related business. TEXLAB INDUSTRIES - company launched by Late Shree AMBALAL MISTRY for local and global region with t...
N-(1,3-dioxo-1,3-dihydroisobenzofuran-4-yl) acetam...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Nantong Chem-land Co., Ltd. is located in Nantong city, a developed port city which distance from Shanghai is only 1.5 hours by car. Established in 2006, we have developed quickly into ...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Pluvia Consumer Health is a multinational pharmaceutical company with its head office in Turkey/Istanbul & with unique molecules & know-how. Our portfolio contains several specific APIs...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : We are one of the well-known manufacturers of key APIs & intermediates in China, with 20 years of experience & presence in 20+ countries. At Boyuan, we are committed to providing high-q...
CAS Number : 6296-53-3
End Use API :
End Use API : Apremilast
About the Company : Srini Pharmaceuticals Pvt. Ltd., was established in 1995. USFDA, TGA and KFDA approved fully integrated global pharmaceutical company, located just about 60 KM's away from the Pharma Ca...